Drug Shortage Report for ACT METHYLPHENIDATE ER
Report ID | 65996 |
Drug Identification Number | 02441950 |
Brand name | ACT METHYLPHENIDATE ER |
Common or Proper name | METHYLPHENIDATE |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | METHYLPHENIDATE HYDROCHLORIDE |
Strength(s) | 36MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N06BA |
ATC description | PSYCHOSTIMULANTS AND NOOTROPICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-02-28 |
Estimated end date | 2024-02-10 |
Actual end date | 2024-02-12 |
Shortage status | Resolved |
Updated date | 2024-02-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v42 | 2024-02-13 | French | Compare |
v41 | 2024-02-13 | English | Compare |
v40 | 2022-06-28 | French | Compare |
v39 | 2022-06-28 | English | Compare |
v38 | 2022-06-09 | French | Compare |
v37 | 2022-06-09 | English | Compare |
v36 | 2022-03-17 | French | Compare |
v35 | 2022-03-17 | English | Compare |
v34 | 2021-06-30 | French | Compare |
v33 | 2021-06-30 | English | Compare |
v32 | 2020-08-20 | French | Compare |
v31 | 2020-08-20 | English | Compare |
v30 | 2020-06-25 | French | Compare |
v29 | 2020-06-25 | English | Compare |
v28 | 2020-06-11 | French | Compare |
v27 | 2020-06-11 | English | Compare |
v26 | 2020-04-23 | French | Compare |
v25 | 2020-04-23 | English | Compare |
v24 | 2020-03-05 | French | Compare |
v23 | 2020-03-05 | English | Compare |